Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Non-homologous end-joining | R-HSA-5693571 | map03450 | oxantel | 15723 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | tetroquinone | 8307 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | tetroquinone | 8307 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | tetroquinone | 8307 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tetroquinone | 8307 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | tetroquinone | 8307 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tetroquinone | 8307 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | tetroquinone | 8307 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | tetroquinone | 8307 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | tetroquinone | 8307 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | tetroquinone | 8307 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | amiprilose | 121928 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | amiprilose | 121928 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | amiprilose | 121928 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | amiprilose | 121928 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | amiprilose | 121928 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | amiprilose | 121928 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | amiprilose | 121928 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | amiprilose | 121928 | drug-path |
Basal cell carcinoma | R-HSA-5626181 | map05217 | amiprilose | 121928 | drug-path |